Novartis and Medicines for Malaria Venture (MMV) announced the launch of Coartem® Dispersible, a new pediatric formulation of Coartem® (artemether/lumefantrine 20 mg/120 mg), for the treatment of uncomplicated malaria in infants and children.
Pages
Medical Billing News
- International Iberian Nanotechnology Laboratory orders for Vistec’s EBPG5200 electron-beam lithography system
- DSM Pharma launches InnoSyn to implement economical, scalable routes
- Salmonella Enteritidis Outbreak in Shell Eggs
- FDA Cautions Consumers about Estrella Family Creamery Cheeses
- Infants And Young Children Who Don’t Sleep Enough At Night Have Higher Risk Of Obesity Later On